?

Schneider Jennifer

Director
Vertex Pharmaceuticals Incorporated
US, Boston [HQ]
CIK 1783060

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
922
Price per Share :
$419.92
Equivalence :
$387,166.24

Transaction History

  • A
    Form 4
    922 Shares After Transaction
    Value : $n/a
    $0.0
    05/15/24
  • Footnotes:
    #1 Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.